The Biginelli Reaction (Figure 1) is an acid catalyzed, threecomponent reaction between an aldehyde, b-ketoester, and urea that produces tetrahydropyrimidones, which have potential pharmaceutical applications.

Biginelli Reaction

Figure 1.

This reaction was first reported in 1893 and has increased interest because of the final products close structural relationship to the clinically important dihydropyrimidines.1 These compounds are known to show biological activities such as antiviral, antitumor, antibacterial, anti-inflammatory, and more recently, antihypertensive agents.2

The mechanism for this reaction is believed to first be the condensation between the aldehyde and the urea. This produces an iminium intermediate that is the electrophile for the nucleophilic addition of the ketoester enol. The ketone carbonyl that is formed then goes under a condensation reaction with the NH2 of the urea. This gives the cyclized final product.

Materials
Loading

References

1.
Kappe, C.O. J. . 1997. Org. Chem. .(62):7201–7204.
2.
Rafiee E, Jafari H. 2006. A practical and green approach towards synthesis of dihydropyrimidinones: Using heteropoly acids as efficient catalysts. Bioorganic & Medicinal Chemistry Letters. 16(9):2463-2466. http://dx.doi.org/10.1016/j.bmcl.2006.01.087

Social Media

LinkedIn icon
Twitter icon
Facebook Icon
Instagram Icon

MilliporeSigma

Research. Development. Production.

We are a leading supplier to the global Life Science industry with solutions and services for research, biotechnology development and production, and pharmaceutical drug therapy development and production.

© 2021 Merck KGaA, Darmstadt, Germany and/or its affiliates. All Rights Reserved.

Reproduction of any materials from the site is strictly forbidden without permission.